Herborium Group logo

Herborium Group(OTC) HBRM

Market Cap$1.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-100%
5 Year-89%
1 Year+0%
1 Month+9,900%
$0.00
+0.00%
+0.00Today
Herborium Group last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-23
Herborium Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-10-16
1 month+9,900%USD 0.002026-09-23
3 month+0%USD 0.002026-07-24
Year to date+100%USD 0.002025-12-31
1 year+0%USD 0.002025-10-23
3 year+9,900%USD 0.002023-10-24
5 year-88.89%USD 0.002021-10-22
Since inception-100%USD 60.002006-09-19

Herborium Group Financials at a Glance

Market Cap

$1.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$812.05K

Net Income (TTM)

-$239.85K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

7.82 (High)

Price

$0.00

Volume

8,940

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jan 29, 2025

HBRM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Herborium Group

Herborium Group, Inc. specializes in botanical therapeutics, focusing on the development and commercialization of plant-based medicinal products. The company offers a range of solutions targeting dermatological issues, sexual health, and energy enhancement.

Products and Services
  • AcnEase, an herbal treatment for hormonal acne and Rosacea
  • Non-prescription sexual health products for various dysfunctions
  • Lasting Energy, an herbal supplement for energy depletion and hangover relief
Growth Outlook
  • Recent quarterly revenue increased to $29,250, showing potential for growth
  • Strong gross profit margin of 52% indicates effective cost management
  • Expansion into the UK and mainland Europe enhances market reach
Financial Highlights
  • Trailing twelve months (TTM) revenue of $292,250 reflects a growing customer base
  • Operating expenses decreased significantly, improving financial efficiency
  • Cash flow from operations reached $101,420 in the latest quarter
Herborium Group, Inc. operates in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. The company has developed a unique portfolio of botanical therapeutics that cater to various health needs, including skin conditions and sexual health issues. The recent increase in quarterly revenue and strong gross profit margins suggest a positive trajectory for the company. The expansion into international markets, particularly in the UK and mainland Europe, positions Herborium for further growth. The company's ability to manage operating expenses effectively has also contributed to improved financial efficiency. With a focus on innovative, plant-based solutions, Herborium Group, Inc. presents an intriguing opportunity for potential investors interested in the healthcare and wellness sectors.
AI Generated • Oct 24, 2026

Industry

Personal Products

Employees

6

CEO

Agnes Paulina Olszewski, PhD, MBA

Headquarters

Sugar Land, TX 77478, US

HBRM Financials

Key Financial Metrics (TTM)

Gross Margin

59.02%

Operating Margin

-36.88%

Net Income Margin

-29.54%

Return on Equity

5.58%

Return on Capital

N/A

Return on Assets

-203.87%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

11.42B

Volume

8.94K

Avg. Volume

657.02K

Financials (TTM)

Gross Profit

$479.30K

Operating Income

-$299.45K

EBITDA

-$299.45K

Operating Cash Flow

$197.07K

Capital Expenditure

$0.00

Free Cash Flow

$197.07K

Cash & ST Invst.

$2.55K

Total Debt

$867.50K

Herborium Group Performance Analysis

Herborium Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-11-30USD 1,133,1007.8%
20232023-11-30USD 1,119,420-1.2%
20242024-11-30USD 1,051,000-6.1%
20252025-11-30USD 788,250-25.0%
Herborium Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-11-30615.4%
Q12026-02-28-37.2%
Q22026-05-31-89.1%
Q32026-08-31190.6%
Herborium Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-11-30USD 0.00N/A
20232023-11-30USD 0.00N/A
20242024-11-30USD 0.00N/A
20252025-11-30USD 0.00N/A
Herborium Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-11-30N/A
Q12026-02-28N/A
Q22026-05-31N/A
Q32026-08-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$85.00K

+41.9%

Gross Profit

$40.00K

-2.2%

Gross Margin

47.06%

N/A

Market Cap

$1.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$570.95K

N/A

Employees

2

N/A

Net Income

-$18.01K

-102.4%

EBITDA

-$18.00K

-102.2%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$2.55K

-63.6%

Total Debt

$867.50K

+116.0%

Accounts Receivable

$1.65K

-83.1%

Inventory

$3.00K

-40.0%

Long Term Debt

$667.50K

N/A

Short Term Debt

$200.00K

-50.2%

Return on Assets

-2.04%

N/A

Return on Invested Capital

9.00%

N/A

Free Cash Flow

-$5.60K

-103.4%

Operating Cash Flow

-$5.60K

-103.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MJNAMedical Marijuana, Inc.
$0.00+100.00%
PCYNProcyon Corporation
$0.19+0.00%
EDXCEndexx Corporation
$0.00+0.00%
BMCSBioTech Medics, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$11.84-21.93%
EWZiShares - iShares Msci Brazil ETF
$32.03-24.81%
CLROClearOne
$4.20+29.23%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$86.81+3.88%

Questions About HBRM

What is the current price of Herborium Group?

Herborium Group is trading at $0.00 per share.

What is the 52-week range for Herborium Group?

Over the past 52 weeks, Herborium Group has traded between $0.00 and $0.00.

How much debt does Herborium Group have?

As of the most recent reporting period, Herborium Group reported total debt of $867.50K.

How much cash does Herborium Group have on hand?

Herborium Group reported $2.55K in cash and cash equivalents in its most recent financial results.

What is Herborium Group’s dividend yield?

Herborium Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.